| 1. |
- Stridsman, C, et al.
(författare)
-
Predictors of severe COVID-19 in COPD
- 2021
-
Ingår i: EUROPEAN RESPIRATORY JOURNAL. - 0903-1936. ; 58
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Larsson, K., et al.
(författare)
-
Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register
- 2021
-
Ingår i: International Journal of Chronic Obstructive Pulmonary Disease. - 1178-2005. ; 16, s. 909-918
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction: Swedish guidelines adhere to the international GOLD document regarding management of chronic obstructive pulmonary disease (COPD). Based on data from the Swedish National Airway Register (SNAR) the aim was to evaluate adherence to guidelines of pharmacological treatment of COPD in Swedish primary and secondary care. Methods: During a period of 18 months, data on symptoms (CAT, mMRC), lung function, exacerbation history and pharmacological treatment from 15,595 COPD patients from 853 primary care and 125 secondary care clinics were collected from SNAR. Patients with a co-diagnosis of asthma were excluded. Patients were divided into four treatment groups: no pharmacological treatment, short-acting bronchodilators alone, long-acting bronchodilators alone and ICS alone or in combination with bronchodilators. Results: Of the patients, 29% were in GOLD group A, 58% in group B, 2% in group C and 11% in group D. CAT score was >= 10 and mMRC score was below 2 in 30.9% of the patients and mMRC score was >= 2 and CAT score <10 in 4.2% of the patients. In 61.4% of the patients, no exacerbation was registered during the last year. Long-acting bronchodilators were prescribed for 78% and ICS for 46% of all patients. In groups A, B, C and D, respectively, 21%, 11%, 11% and 5% did not receive any inhaler therapy; 67%, 81%, 81% and 90% received long-acting bronchodilators; 33%, 46%, 55% and 71% received any ICS containing therapy and 19%, 34%, 39% and 61% received triple therapy. Discussion: Data from the SNAR indicate that only a minority of COPD patients were untreated. There was a liberal use of ICS containing drug combinations in subjects who do not have an indication for ICS. A considerable proportion of subjects at high risk of exacerbations did not receive ICS treatment.
|
|
| 5. |
- Lindberg, Anne, et al.
(författare)
-
Low nicotine dependence and high self-efficacy can predict smoking cessation independent of the presence of chronic obstructive pulmonary disease: a three year follow up of a population-based study
- 2015
-
Ingår i: Tobacco Induced Diseases. - : E.U. European Publishing. - 1617-9625. ; 13
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), and smoking cessation is the only intervention that slows disease progression. It is important to know whether current factors related to smoking and smoking cessation are different among subjects with and without COPD in order to support smoking cessation. The aim of this study was to evaluate factors related to smoking cessation and to compare characteristics and nicotine dependence among smokers with and without COPD. Methods: In 2005, 1614 subjects in a population-based longitudinal study of subjects with COPD and controls were examined. The Fagerstrom Test for Nicotine Dependence (FTND) and motivation for smoking cessation were assessed for current smokers (n = 299 total, 194 with COPD). Data on smoking cessation were collected in a follow-up in 2008 (n = 240). Results: Smokers with COPD had more pack-years and respiratory symptoms than smokers without COPD, whereas higher FTND scores were associated with anxiety/depression and respiratory symptoms in both groups. Nineteen percent of the smokers had quit smoking by the follow-up 3 years later, and they had significantly lower FTND scores (2.54 vs. 3.75, p < 0.001) and higher self-efficacy scores (10.0 vs. 6.0, p = 0.020) at baseline than the sustained smokers. Smoking cessation was related to low FTND scores and high self-efficacy independent of the presence of COPD, respiratory symptoms, anxiety/depression, and heart disease. Conclusions: The FTND score and a simple visual analog scale for assessing self-efficacy seem to be valuable instruments for predicting smoking cessation over several years, independent of COPD, respiratory symptoms, presence of anxiety/depression, and heart disease.
|
|
| 6. |
- Stridsman, C., et al.
(författare)
-
Nurses specialized through higher education in asthma, allergy and COPD : Experiences from a Swedish perspective - A winning concept for the clinic
- 2022
-
Ingår i: European Respiratory Journal. - : European Respiratory Society. - 0903-1936 .- 1399-3003. ; 60:Suppl. 66
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Background: In Sweden, asthma, allergy and COPD clinics are a successful model for evidence-based care. The main criteria for the clinic is that it should be led by an educated asthma, allergy and COPD-nurse. Further, allergy consultant nurses have the main task to be a bridge between health care and the family/preschool/school/work.Aim: To describe the Swedish nursing education courses of an asthma, allergy and COPD nurse and an allergy consultant nurse.Methods/results: To become specialized, the nurse need further university studies in asthma, allergy and COPD after bachelor degree, i.e. at least 15 credits. This can also be followed up by further credits and a master’s degree. The courses are designed with a person-centered approach as a mix of nursing and medicine. It includes early detection, screening and diagnosis of asthma, allergy and COPD and skills about spirometry, allergy testing, patient education, smoking cessation support and the use of a written treatment-plan as well as assessment of risk factors, comorbidities, and symptoms i.e. both non-pharmacological and pharmacological interventions. Self-management, interprofessional collaboration and how to evaluate adherence to guidelines by using the Swedish National Airway Register are highlighted in the course. The allergy consultant nurse receives deeper education in allergy and the immunological mechanisms. The consultant often has postgraduate credits in specialist nursing or a master of science with a specialisation in paediatric and adolescent healthcare.Conclusion: Advanced education after bachelor’s degree has benefits both for the patient and for the society.
|
|
| 7. |
|
|
